Anna Nyhlén
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Substance Abuse Treatment and Outcomes 4
- Pneumonia and Respiratory Infections 2
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Mats Fridell (4 shared papers)Sheryl Zelenitsky (3 shared papers)Daniel Sitar (3 shared papers)Robert E. Ariano (3 shared papers)J. Peter Donnelly (2 shared papers)G. K. M. Harding (1 shared paper)Peter Krantz (3 shared papers)Morten Hesse (3 shared papers)
In The Last Decade
Anna Nyhlén
11 papers receiving 374 citations
Peers
Comparison fields: 5 of 77
- Applied Microbiology and Biotechnology 62
- Molecular Medicine 87
- Pharmacology 210
- Epidemiology 195
- Clinical Biochemistry 37
Countries citing papers authored by Anna Nyhlén
This map shows the geographic impact of Anna Nyhlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Nyhlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Nyhlén more than expected).
Fields of papers citing papers by Anna Nyhlén
This network shows the impact of papers produced by Anna Nyhlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Nyhlén. The network helps show where Anna Nyhlén may publish in the future.
Co-authors
The 18 scholars most cited alongside Anna Nyhlén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 158 | |
| 2 | 2011 | 51 | |
| 3 | 2019 | 42 | |
| 4 | 2011 | 33 | |
| 5 | 2002 | 29 | |
| 6 | 1997 | 27 | |
| 7 | 2015 | 26 | |
| 8 | 2005 | 7 | |
| 9 | 2002 | 6 | |
| 10 | 1999 | 3 | |
| 11 | 2003 | 1 |
About Anna Nyhlén
Anna Nyhlén is a scholar working on Epidemiology, Pharmacology, Molecular Medicine, Clinical Biochemistry and Public Health, Environmental and Occupational Health, having authored 11 papers that have together received 383 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Substance Abuse Treatment and Outcomes (4 papers), Antibiotic Resistance in Bacteria (4 papers), Opioid Use Disorder Treatment (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Alcohol Consumption and Health Effects (2 papers), Pneumonia and Respiratory Infections (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (62 citations), Molecular Medicine (87 citations), Pharmacology (210 citations), Epidemiology (195 citations) and Clinical Biochemistry (37 citations). Anna Nyhlén has collaborated with scholars based in Sweden, Canada and Denmark. Frequent co-authors include Mats Fridell, Sheryl Zelenitsky, Daniel Sitar, Robert E. Ariano, J. Peter Donnelly, G. K. M. Harding, Peter Krantz, Morten Hesse, Martin Bäckström and I. Nilsson-Ehle. Their work appears in journals such as Chemotherapy, BMC Psychiatry, European Journal of Clinical Microbiology & Infectious Diseases, The Journal of Clinical Pharmacology and Journal of Forensic and Legal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.